FDA.reportPublic FDA data

Brukinsa 160 MG Oral Tablet

RxCUI
2719223
RxNorm name
Brukinsa 160 MG Oral Tablet
Display name
Brukinsa 160 MG Oral Tablet
Full name
Brukinsa 160 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e08fe23-d70e-424c-bc51-1222e320f902Brukinsa 160 MG Oral Tablet [PSN] · zanubrutinib 160 MG Oral Tablet [Brukinsa] [SBD] · Brukinsa 160 MG Oral Tablet [SY]322These highlights do not include all the information needed to use BRUKINSA safely and effectively. See full prescribing information for BRUKINSA. BRUKINSA ® (zanubrutinib) capsules, for oral use BRUKINSA ® (zanubrutinib) tablets, for oral use Initial U.S. Approval: 201920260202